Previous incidents

The login issue has been resolved and all users should be able to access Molecule as usual. We apologize for the inconvenience.

The queue of jobs has completed processing with the exception of building forward-dated valuation entries which are largely irrelevant for today. Application performance has been restored back to normal and is expected to stay that way. We apologize for any inconvenience this may have caused.